Therapeutic value of clofarabine in younger and middle-aged (18-65 years) adults with newly diagnosed AML

Bob Löwenberg; T Pabst; J Maertens; Yvette van Norden; BJ Biemond; HC Schouten; O Spertini; E Vellenga; C Graux; V Havelange; Georgine Greef; O de Weerdt; M Legdeur; J Kuball; MVM Kooy; BT Gjertsen; Mojca Jongen - Lavrencic; AAV de Loosdrecht; D van Lammeren-Venema; B Hodossy; DA Breems; Y Chalandon; J Passweg; Peter Valk; MG Manz; GJ Ossenkoppele

doi:10.1182/blood-2016-10-740613

Therapeutic value of clofarabine in younger and middle-aged (18-65 years) adults with newly diagnosed AML

Bob Löwenberg, T Pabst, J Maertens, Yvette van Norden, BJ Biemond, HC Schouten, O Spertini, E Vellenga, C Graux, V Havelange, Georgine Greef, O de Weerdt, M Legdeur, J Kuball, MVM Kooy, BT Gjertsen, Mojca Jongen - Lavrencic, AAV de Loosdrecht, D van Lammeren-Venema, B HodossyDA Breems, Y Chalandon, J Passweg, Peter Valk, MG Manz, GJ Ossenkoppele

Hematology

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Pages (from-to)	1636-1645
Number of pages	10
Journal	Blood
Volume	129
Issue number	12
DOIs	https://doi.org/10.1182/blood-2016-10-740613
Publication status	Published - 2017

Access to Document

10.1182/blood-2016-10-740613

http://hdl.handle.net/1765/98962

Cite this

Löwenberg, B., Pabst, T., Maertens, J., van Norden, Y., Biemond, BJ., Schouten, HC., Spertini, O., Vellenga, E., Graux, C., Havelange, V., Greef, G., de Weerdt, O., Legdeur, M., Kuball, J., Kooy, MVM., Gjertsen, BT., Jongen - Lavrencic, M., de Loosdrecht, AAV., van Lammeren-Venema, D., ... Ossenkoppele, GJ. (2017). Therapeutic value of clofarabine in younger and middle-aged (18-65 years) adults with newly diagnosed AML. Blood, 129(12), 1636-1645. https://doi.org/10.1182/blood-2016-10-740613

@article{be02cfc4782f473eaf83fcc12983b89c,

title = "Therapeutic value of clofarabine in younger and middle-aged (18-65 years) adults with newly diagnosed AML",

author = "Bob L{\"o}wenberg and T Pabst and J Maertens and {van Norden}, Yvette and BJ Biemond and HC Schouten and O Spertini and E Vellenga and C Graux and V Havelange and Georgine Greef and {de Weerdt}, O and M Legdeur and J Kuball and MVM Kooy and BT Gjertsen and {Jongen - Lavrencic}, Mojca and {de Loosdrecht}, AAV and {van Lammeren-Venema}, D and B Hodossy and DA Breems and Y Chalandon and J Passweg and Peter Valk and MG Manz and GJ Ossenkoppele",

year = "2017",

doi = "10.1182/blood-2016-10-740613",

language = "Undefined/Unknown",

volume = "129",

pages = "1636--1645",

journal = "Blood",

issn = "0006-4971",

publisher = "American Society of Hematology",

number = "12",

}

Löwenberg, B, Pabst, T, Maertens, J, van Norden, Y, Biemond, BJ, Schouten, HC, Spertini, O, Vellenga, E, Graux, C, Havelange, V, Greef, G, de Weerdt, O, Legdeur, M, Kuball, J, Kooy, MVM, Gjertsen, BT, Jongen - Lavrencic, M, de Loosdrecht, AAV, van Lammeren-Venema, D, Hodossy, B, Breems, DA, Chalandon, Y, Passweg, J, Valk, P, Manz, MG & Ossenkoppele, GJ 2017, 'Therapeutic value of clofarabine in younger and middle-aged (18-65 years) adults with newly diagnosed AML', Blood, vol. 129, no. 12, pp. 1636-1645. https://doi.org/10.1182/blood-2016-10-740613

TY - JOUR

T1 - Therapeutic value of clofarabine in younger and middle-aged (18-65 years) adults with newly diagnosed AML

AU - Löwenberg, Bob

AU - Pabst, T

AU - Maertens, J

AU - van Norden, Yvette

AU - Biemond, BJ

AU - Schouten, HC

AU - Spertini, O

AU - Vellenga, E

AU - Graux, C

AU - Havelange, V

AU - Greef, Georgine

AU - de Weerdt, O

AU - Legdeur, M

AU - Kuball, J

AU - Kooy, MVM

AU - Gjertsen, BT

AU - Jongen - Lavrencic, Mojca

AU - de Loosdrecht, AAV

AU - van Lammeren-Venema, D

AU - Hodossy, B

AU - Breems, DA

AU - Chalandon, Y

AU - Passweg, J

AU - Valk, Peter

AU - Manz, MG

AU - Ossenkoppele, GJ

PY - 2017

Y1 - 2017

U2 - 10.1182/blood-2016-10-740613

DO - 10.1182/blood-2016-10-740613

M3 - Article

VL - 129

SP - 1636

EP - 1645

JO - Blood

JF - Blood

SN - 0006-4971

IS - 12

ER -